Influenza vaccination in childhood and adolescence. Evaluation of the 2025-2026 campaign in Spain and improvement strategies. Report by AEV, CAV-AEP and SEIP.
Javier Alvarez Aldeán, Francisco José Alvarez García, Fernando Baquero Artigao, Marta Cruz Cañete, María Fernández Prada, Laura Francisco González, Ana María Grande Tejada, Antonio Iofrío de Arce, Alejandra Méndez Sánchez, Fernando Moraga Llop, Ignacio Salamanca de la Cueva
{"title":"Influenza vaccination in childhood and adolescence. Evaluation of the 2025-2026 campaign in Spain and improvement strategies. Report by AEV, CAV-AEP and SEIP.","authors":"Javier Alvarez Aldeán, Francisco José Alvarez García, Fernando Baquero Artigao, Marta Cruz Cañete, María Fernández Prada, Laura Francisco González, Ana María Grande Tejada, Antonio Iofrío de Arce, Alejandra Méndez Sánchez, Fernando Moraga Llop, Ignacio Salamanca de la Cueva","doi":"10.1016/j.anpede.2026.504373","DOIUrl":null,"url":null,"abstract":"<p><p>Seasonal influenza represents a significant burden in childhood. This article analyzes pediatric influenza vaccination during the 2025-2026 campaign, as well as epidemiological, effectiveness, and preliminary vaccination coverage data. Routine vaccination against influenza between ages 6 and 59 months, as well as the extension of the recommendation up to 17 years, as outlined in the 2025 AEV, CAV-AEP, and SEIP consensus document, is key to individual and collective protection. We propose advancing further in developing effective strategies to continue increasing vaccination coverage, as well as expanding the age range for vaccination, as has already been implemented in some autonomous communities in 2025-2026.</p>","PeriodicalId":93868,"journal":{"name":"Anales de pediatria","volume":" ","pages":"504373"},"PeriodicalIF":0.0000,"publicationDate":"2026-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Anales de pediatria","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.anpede.2026.504373","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Seasonal influenza represents a significant burden in childhood. This article analyzes pediatric influenza vaccination during the 2025-2026 campaign, as well as epidemiological, effectiveness, and preliminary vaccination coverage data. Routine vaccination against influenza between ages 6 and 59 months, as well as the extension of the recommendation up to 17 years, as outlined in the 2025 AEV, CAV-AEP, and SEIP consensus document, is key to individual and collective protection. We propose advancing further in developing effective strategies to continue increasing vaccination coverage, as well as expanding the age range for vaccination, as has already been implemented in some autonomous communities in 2025-2026.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
